Mynd Healthcare

Library / regulatory-reference

Tanzania: Tanzania Medicines and Medical Devices Authority (TMDA)

Audience: administrators-policy, researchers-scientists ยท Review state: published

The national authority

The Tanzania Medicines and Medical Devices Authority, known as TMDA, is Tanzania's national regulator for medicines and medical devices. It was established in 2019 as the successor to the former food and drugs authority, taking over medicines and devices while food oversight moved to the national standards body.

Tanzania is one of East Africa's largest medicines markets, supplied mainly by imports, and the authority's registration and port-inspection work governs what enters the country.

How products enter the market

Medicines and devices require registration after evaluation of quality, safety and efficacy, and premises, importers and wholesalers are licensed. Imported consignments are subject to inspection and sampling at ports of entry.

Post-market work includes pharmacovigilance reporting, market surveillance and recalls, with laboratory testing support for quality control.

Regional and international role

The authority participates in African regional harmonization, including joint assessment and reliance work among East African regulators, which shortens review timelines across the region.

Its reorganization from a combined food-and-drugs body into a dedicated medicines authority is watched as a structural model in the region.

Using this profile

The authority publishes guidelines, registers and safety communications in English and Swahili through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.

For cross-country comparison: the TMDA illustrates the specialized successor authority: a medicines-and-devices regulator carved out of a broader food-and-drugs agency to focus oversight.

Limitations

Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.